Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs acetaminophen for acute phase response after zoledronate in postmenopausal osteoporosis
TCTR20260715009Phase 0Not yet recruiting
- Sponsor
- Maha Vajiralongkorn Foundation
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of dexamethasone, acetaminophen and zoledronate in postmenopausal osteoporosis (2 arms), sponsored by Maha Vajiralongkorn Foundation. Primary endpoint: Acute phase response severity. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dexamethasoneacetaminophenzoledronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on TCTR20260715009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260715009.